Treatments for lung cancer have improved significantly over the last decade. During the last 10 years, newer medications have emerged that are helping people live longer and better quality lives. One of those discoveries was targeted therapies.
Because targeted therapies focus on killing cancer cells and spare the healthy cells, they tend to cause less side effects than chemotherapy.
American Cancer Society. (2023). Treatment choices for non-small cell lung cancer, by stage.
American Cancer Society. (2022). Targeted therapy drugs for non-small cell lung cancer.
UpToDate. (2021). Non-small cell lung cancer treatment; stage IV cancer (Beyond the Basics).
UpToDate. (2023). Overview of the initial treatment of advanced non-small cell lung cancer.
Zhang, C, et al. (2019). Emerging therapies for non-small cell lung cancer. Journal of Hematology & Oncology.